HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 192 filers reported holding HORIZON PHARMA PLC in Q2 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,509,000 | +2.8% | 128,393 | +3.0% | 0.60% | +24.4% |
| Q3 2018 | $2,441,000 | +21.1% | 124,659 | +2.5% | 0.48% | +16.8% |
| Q2 2018 | $2,015,000 | +11.1% | 121,659 | -4.7% | 0.41% | +7.0% |
| Q1 2018 | $1,813,000 | +32.3% | 127,659 | +36.0% | 0.38% | +0.5% |
| Q4 2017 | $1,370,000 | +73.2% | 93,859 | +50.4% | 0.38% | +69.8% |
| Q3 2017 | $791,000 | +30.3% | 62,393 | +22.0% | 0.22% | +50.0% |
| Q2 2017 | $607,000 | -19.7% | 51,142 | 0.0% | 0.15% | -16.2% |
| Q1 2017 | $756,000 | -8.6% | 51,142 | 0.0% | 0.18% | -13.1% |
| Q4 2016 | $827,000 | -10.8% | 51,142 | 0.0% | 0.21% | -11.2% |
| Q3 2016 | $927,000 | +17.0% | 51,142 | +124.3% | 0.23% | +60.0% |
| Q2 2015 | $792,000 | -58.4% | 22,800 | -68.9% | 0.14% | -59.9% |
| Q1 2015 | $1,902,000 | +100.4% | 73,235 | -0.6% | 0.36% | +97.8% |
| Q4 2014 | $949,000 | +94800.0% | 73,650 | +66251.4% | 0.18% | – |
| Q3 2014 | $1,000 | – | 111 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,664,219 | $83,717,000 | 10.14% |
| Consonance Capital Management LP | 6,218,903 | $91,915,000 | 9.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,944,988 | $161,767,000 | 6.24% |
| Rhenman & Partners Asset Management AB | 1,751,322 | $25,885,000 | 4.10% |
| SCOPIA CAPITAL MANAGEMENT LP | 9,686,262 | $143,163,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 850,000 | $12,563,000 | 2.59% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,959,258 | $43,738,000 | 2.40% |
| Proxima Capital Management, LLC | 246,311 | $3,640,000 | 2.22% |
| Beach Point Capital Management LP | 522,898 | $7,728,000 | 2.18% |
| GRAYBILL WEALTH MANAGEMENT, LTD. | 165,260 | $2,443,000 | 1.94% |